Table 4

Agonist efficacies and potencies at hH2R-A271D-GsαS, NgpChH2R-GsαS, and NhCgpH2R-GsαSexpressed in Sf9 cell membranes

CompoundhH2R-A271D-GsαSNgpChH2R-GsαSNhCgpH2R-GsαS
EfficacyEC50Rel. Pot.EfficacyEC50Rel. Pot.EfficacyEC50Rel. Pot.
μM μM μM
1(HIS)1.000.35  ± 0.051001.001.98  ± 0.671001.000.71  ± 0.26100
5 (IMP)0.85  ± 0.120.03  ± 0.0113000.78  ± 0.100.19  ± 0.0310400.99  ± 0.090.04  ± 0.011780
6 (BU-E-42)0.95  ± 0.080.08  ± 0.014380.87  ± 0.020.25  ± 0.047920.91  ± 0.020.11  ± 0.03645
7 (BU-E-43)0.76  ± 0.090.28  ± 0.041250.70  ± 0.030.21  ± 0.039430.79  ± 0.010.46  ± 0.03154
8 (ARP)0.91  ± 0.040.06  ± 0.015830.95  ± 0.060.27  ± 0.047330.93  ± 0.060.11  ± 0.05645
10 (BU-E-48)0.83  ± 0.040.03  ± 0.0011700.85  ± 0.030.12  ± 0.0216500.85  ± 0.030.08  ± 0.02888
11 (BU-E-75)0.80  ± 0.100.04  ± 0.018750.91  ± 0.060.19  ± 0.0110400.97  ± 0.050.09  ± 0.01789
13 (D281)0.62  ± 0.110.11  ± 0.023180.45  ± 0.060.16  ± 0.0512400.52  ± 0.140.13  ± 0.04546

Potencies and efficacies of ligands at hH2R-A271D-GsαS, NgpChH2R-GsαS, and NhCgpH2R-GsαS were determined in the GTPase assay. GTP hydrolysis was determined as described under Experimental Procedures. Reaction mixtures contained Sf9 membranes expressing fusion proteins and agonists at concentrations from 1 nM to 1 mM as appropriate to generate saturated concentration/response curves. Curves were analyzed by nonlinear regression. Typical basal GTPase activities ranged between ∼1 and 2 pmol/mg/min, and typical GTPase activities stimulated by HIS (100 μM) ranged between ∼4 and 8 pmol/mg/min. To calculate agonist efficacies, the maximum stimulatory effect of HIS was set at 1.00, and the stimulatory effects of other agonists were referred to this value. Data shown are the means ± S.D. of three to six experiments performed in duplicates. The relative potency (Rel. Pot.) of HIS was set at 100, and the potencies of other agonists were referred to this value to facilitate comparison of agonist potencies with hH2R-GsαS and gpH2R-GsαS(Table 2).